Pharmacist Tapering Opioids and Benzodiazepines Education Assessment

At the end of this assessment you will be re-directed to your certificate of completion. Your name will NOT fill in automatically. Please save a copy of this certificate for your records in the event that you are audited by Licensure.

Question Title

* 1. Contact Information

Name

Email Address

Phone Number

Question Title

* 2. Opioids should be weaned, rather than abruptly stopped, after chronic use, which is defined as 30 days or more.

True

False

Question Title

* 3. Initial steps of tapering a patient on opioids include:

Calculation of MME

review of risk-screening assessments

Assessment of patient progress in treatment

All of the above

Question Title

* 4. A full tapering flow sheet for opioids is available in the Pain Management Guidance Document.

True

False

Question Title

* 5. Unlike opioids, abrupt withdrawal from high doses of benzodiazepines can result in seizures and death.

True

False

Question Title

* 6. General considerations with tapering both opoids and benzodiazepines include:

Avoiding concomitant use of benzodiazepines and opioids due to the synergistic effect of the two

Check for benzodiazepine use by UDS, PDMP query, s well as observing for impairment of sedation

Use of psychotherapy

All of the above

You will now be re-directed to your certificate of completion. Your name will NOT fill in automatically. Please save a copy of this certificate for your records in the event that you are audited by Licensure.

If you would like to request a transcript of the continuing education you have completed, please email your name and profession type to dhhs.pdmp@nebraska.gov.